Proteonomix, Inc.
PROT · OTC
6/30/2012 | 3/31/2012 | 12/31/2011 | 9/30/2011 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.00 | 0.04 | -0.01 |
| FCF Yield | -116.06% | -22.88% | -52.39% | -12.31% |
| EV / EBITDA | 0.87 | -1.20 | -12.62 | -14.64 |
| Quality | ||||
| ROIC | -28.74% | -58.59% | 181.83% | -865.99% |
| Gross Margin | 0.00% | 74.45% | 648.27% | -338.49% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -50.42% | -48.90% | -46.09% | -42.45% |
| Free Cash Flow Growth | -14.90% | -213.13% | -141.81% | -49.92% |
| Safety | ||||
| Net Debt / EBITDA | 0.53 | -0.11 | -11.57 | -12.69 |
| Interest Coverage | -54.23 | -117.78 | -23.24 | -18.15 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | -0.20 | 0.20 |
| Cash Conversion Cycle | 0.00 | -464,030.76 | -181.84 | 695.20 |